Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was ...

At a single academic tertiary referral center, mild intraocular inflammation developed in four eyes following intravitreal ...

As part of our Masterclass series, GP specialist in diabetes Dr Elizabeth Martin explains the key points in prevention, ...

Luo, Y.N., Lu, J., Liang, G.H. and Ma, W.H. (2025) Long-Term Opacity of Intraocular Lens after Cataract Surgery in 1 Case. Journal of Biosciences and Medicines, 13, 206-214. doi: ...

"OCU200 has the potential to change the treatment landscape for DME, diabetic retinopathy (DR), and wet age-related ... dose-escalation study to assess drug safety via intravitreal injection in three ...

By Katie Thomas Maricruz Salgado was bringing her diabetes under control. Thanks to a federal program that allowed health clinics that serve poor people to buy drugs at steeply discounted prices ...